ArticleiScience2026
CATS-A tool to contextualize cancer hallmarks to specific cancer types.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gene signatures, widely used to infer the activity of biological processes based on transcriptomic data, lack tissue/cellular context. For instance, the epithelial-mesenchymal transition (EMT) signature derived from one cellular context may not be precisely applicable to another context; overlapping yet distinct genesets are likely to mediate EMT in different contexts. Here, we derive cancer type-specific gene signatures for 14 oncogenic hallmark processes across 23 cancer types by integrating the context-agnostic reference gene signatures with the protein interaction network and cancer-specific transcriptomic data. Overall, our inferred context-specific gene signatures exhibit a higher cancer specificity than the corresponding reference genesets with respect to a variety of biological and clinical features, such as activity in malignant cells, genetic vulnerabilities, patient prognosis, and treatment response. We provide the projections for 14 cancer hallmarks across 23 human cancer types, along with the CATS (Cancer Specific Transcriptomic Signature) software tool and the evaluation repository.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.